12 Baillie Gifford Burning Rock Biotech Trades
Baillie Gifford started to build up the position in Burning Rock Biotech in Q2 2020 and continued to invest until Q1 2022. Since then they sold 891k shares. The investor completely sold their stake between Q2 2022 and Q4 2023.
Avg closing price
Price range
Sold -15.7k shares
Q4 2023
Avg closing price
$0.92
Price range
$0.72
-
$1.13
Sold 2.0% shares (-326 shares)
Q3 2023
Avg closing price
$1.56
Price range
$0.91
-
$2.29
Sold 52.6% shares (-17.8k shares)
Q3 2022
Avg closing price
$3.23
Price range
$2.39
-
$3.96
Sold 96.2% shares (-857k shares)
Q2 2022
Avg closing price
$4.47
Price range
$1.75
-
$10.44
Increased shares by 0.1% (+1.08k shares)
Q1 2022
Avg closing price
$8.69
Price range
$6.70
-
$10.23
Increased shares by 1.2% (+10.8k shares)
Q4 2021
Avg closing price
$13.70
Price range
$9.43
-
$17.14
Increased shares by 3.9% (+33k shares)
Q3 2021
Avg closing price
$22.23
Price range
$17.37
-
$27.92
Increased shares by 28.6% (+188k shares)
Q2 2021
Avg closing price
$29.59
Price range
$26.14
-
$37.45
Increased shares by 317.2% (+500k shares)
Q1 2021
Avg closing price
$30.44
Price range
$23.50
-
$39.58
Increased shares by 55.8% (+56.5k shares)
Q4 2020
Avg closing price
$26.85
Price range
$22.55
-
$30.87
Increased shares by 40.9% (+29.4k shares)
Q3 2020
Avg closing price
$23.70
Price range
$19.07
-
$29.61
New holding (+71.9k shares)
Q2 2020
Avg closing price
$27.41
Price range
$23.21
-
$31.43
